WHEN:  Thursday, September 17, 2020 12:00-2:30 p.m. EST.

WHERE:  Virtual event on Zoom. Link and access code will be provided upon registration.

This event is FREE.

NJ CLE Credits Pending

Panel One: Balancing Privacy and Public Health

Efforts to contain the COVID-19 pandemic can impact privacy rights of patients, those at risk, and the general population.The first panel will include topics addressing: What are the duties of healthcare providers to report patients’ COVID-19 information? How should governments track infected individuals and others at high-risk? How secure are databases containing COVID-19 information?

Panelists:

  1. Rachel Hammond, Data Privacy Officer, New Jersey Department of Health
  2. Helen Oscislawski, Esq., Founder, Attorneys at Oscislawski LLC
  3. Ryan Calo, Lane Powell & D. Wayne Gittinger Endowed Professorship, Associate Professor of Law, University of Washington School of Law
  4. Stacey A. Tovino, Professor of Law, University of Oklahoma College of Law
  5. Moderated by Gaia Bernstein, Technology, Privacy & Policy Professor of Law, Director of the Institute for Privacy Protection, Co-Director of the Gibbons Institute for Law, Science & Technology, Seton Hall University School of Law

Panel Two:  Intellectual Property –  Incentives and Access to Vaccines and Treatments

Patenting drugs and vaccines incentivizes innovation, but patents increase prices and affect availability. The second panel will discuss the options of patenting COVID-19 drugs and vaccines as well as other alternatives pertinent in times of health emergencies, including compulsory licenses, voluntary licenses, and patent pools. 

Panelists :

  1. Esteban Burrone, Head of Policy and Advocacy, Medicines Patent Pool
  2. Sapna Kumar, Law Foundation Professor of Law, Co-Director for the Institute for Intellectual Property and Information Law, The University of Houston Law Center
  3. Nicholson Price, Professor of Law, The University of Michigan Law School
  4. Corey Salsberg, Vice President, Global Head IP Affairs, Novartis
  5. Moderated by David Opderbeck, Professor of Law, Co-Director of the Gibbons Institute of Law, Science & Technology, Seton Hall University School of Law